{"result": "(\"entity\"<|>POTTER<|>PERSON<|>Potter observed the benefits of oral or enteral supplementation on mortality in adults, particularly in sick, malnourished patients over 70 years old.)\n##\n(\"entity\"<|>STRATTON<|>PERSON<|>Stratton analyzed randomized and non-randomized trials in different population groups regarding nutritional supplementation.)\n##\n(\"entity\"<|>MILNE<|>PERSON<|>Milne conducted a meta-analysis in 2006 focusing on the effects of supplementation in elderly patients.)\n##\n(\"entity\"<|>CAWOOD<|>PERSON<|>Cawood studied the efficacy of hyperproteic oral supplements in a systematic review and meta-analysis in 2012.)\n##\n(\"entity\"<|>SO<|>EVENT<|>SO refers to oral supplementation, which was studied for its effects on health outcomes in elderly patients.)\n##\n(\"entity\"<|>NUTRITIONAL INTERVENTION GUIDELINES FOR FRAIL ELDERLY<|>EVENT<|>Guidelines aimed at improving nutritional status and health outcomes in frail elderly individuals.)\n##\n(\"relationship\"<|>POTTER<|>STRATTON<|>Both Potter and Stratton contributed to the understanding of nutritional supplementation in elderly patients<|>7)\n##\n(\"relationship\"<|>MILNE<|>CAWOOD<|>Milne and Cawood both conducted studies related to the effects of nutritional supplementation in elderly populations<|>6)\n##\n(\"relationship\"<|>STRATTON<|>MILNE<|>Stratton analyzed trials that included findings from Milne's meta-analysis on supplementation<|>5)\n##\n(\"relationship\"<|>CAWOOD<|>SO<|>Cawood's study focused on the efficacy of hyperproteic oral supplements, which are a type of SO<|>8)\n##\n(\"relationship\"<|>POTTER<|>SO<|>Potter's observations were specifically about the benefits of SO in elderly patients<|>9)\n##\n(\"relationship\"<|>NUTRITIONAL INTERVENTION GUIDELINES FOR FRAIL ELDERLY<|>SO<|>The guidelines include recommendations for the use of SO to improve health outcomes in frail elderly<|>8)\n<|COMPLETE|>", "input": "\n-Goal-\nGiven a text document that is potentially relevant to this activity and a list of entity types, identify all entities of those types from the text and all relationships among the identified entities.\n \n-Steps-\n1. Identify all entities. For each identified entity, extract the following information:\n- entity_name: Name of the entity, capitalized\n- entity_type: One of the following types: [organization,person,geo,event]\n- entity_description: Comprehensive description of the entity's attributes and activities\nFormat each entity as (\"entity\"<|><entity_name><|><entity_type><|><entity_description>)\n \n2. From the entities identified in step 1, identify all pairs of (source_entity, target_entity) that are *clearly related* to each other.\nFor each pair of related entities, extract the following information:\n- source_entity: name of the source entity, as identified in step 1\n- target_entity: name of the target entity, as identified in step 1\n- relationship_description: explanation as to why you think the source entity and the target entity are related to each other\n- relationship_strength: a numeric score indicating strength of the relationship between the source entity and target entity\n Format each relationship as (\"relationship\"<|><source_entity><|><target_entity><|><relationship_description><|><relationship_strength>)\n \n3. Return output in English as a single list of all the entities and relationships identified in steps 1 and 2. Use **##** as the list delimiter.\n \n4. When finished, output <|COMPLETE|>\n \n######################\n-Examples-\n######################\nExample 1:\nEntity_types: ORGANIZATION,PERSON\nText:\nThe Verdantis's Central Institution is scheduled to meet on Monday and Thursday, with the institution planning to release its latest policy decision on Thursday at 1:30 p.m. PDT, followed by a press conference where Central Institution Chair Martin Smith will take questions. Investors expect the Market Strategy Committee to hold its benchmark interest rate steady in a range of 3.5%-3.75%.\n######################\nOutput:\n(\"entity\"<|>CENTRAL INSTITUTION<|>ORGANIZATION<|>The Central Institution is the Federal Reserve of Verdantis, which is setting interest rates on Monday and Thursday)\n##\n(\"entity\"<|>MARTIN SMITH<|>PERSON<|>Martin Smith is the chair of the Central Institution)\n##\n(\"entity\"<|>MARKET STRATEGY COMMITTEE<|>ORGANIZATION<|>The Central Institution committee makes key decisions about interest rates and the growth of Verdantis's money supply)\n##\n(\"relationship\"<|>MARTIN SMITH<|>CENTRAL INSTITUTION<|>Martin Smith is the Chair of the Central Institution and will answer questions at a press conference<|>9)\n<|COMPLETE|>\n\n######################\nExample 2:\nEntity_types: ORGANIZATION\nText:\nTechGlobal's (TG) stock skyrocketed in its opening day on the Global Exchange Thursday. But IPO experts warn that the semiconductor corporation's debut on the public markets isn't indicative of how other newly listed companies may perform.\n\nTechGlobal, a formerly public company, was taken private by Vision Holdings in 2014. The well-established chip designer says it powers 85% of premium smartphones.\n######################\nOutput:\n(\"entity\"<|>TECHGLOBAL<|>ORGANIZATION<|>TechGlobal is a stock now listed on the Global Exchange which powers 85% of premium smartphones)\n##\n(\"entity\"<|>VISION HOLDINGS<|>ORGANIZATION<|>Vision Holdings is a firm that previously owned TechGlobal)\n##\n(\"relationship\"<|>TECHGLOBAL<|>VISION HOLDINGS<|>Vision Holdings formerly owned TechGlobal from 2014 until present<|>5)\n<|COMPLETE|>\n\n######################\nExample 3:\nEntity_types: ORGANIZATION,GEO,PERSON\nText:\nFive Aurelians jailed for 8 years in Firuzabad and widely regarded as hostages are on their way home to Aurelia.\n\nThe swap orchestrated by Quintara was finalized when $8bn of Firuzi funds were transferred to financial institutions in Krohaara, the capital of Quintara.\n\nThe exchange initiated in Firuzabad's capital, Tiruzia, led to the four men and one woman, who are also Firuzi nationals, boarding a chartered flight to Krohaara.\n\nThey were welcomed by senior Aurelian officials and are now on their way to Aurelia's capital, Cashion.\n\nThe Aurelians include 39-year-old businessman Samuel Namara, who has been held in Tiruzia's Alhamia Prison, as well as journalist Durke Bataglani, 59, and environmentalist Meggie Tazbah, 53, who also holds Bratinas nationality.\n######################\nOutput:\n(\"entity\"<|>FIRUZABAD<|>GEO<|>Firuzabad held Aurelians as hostages)\n##\n(\"entity\"<|>AURELIA<|>GEO<|>Country seeking to release hostages)\n##\n(\"entity\"<|>QUINTARA<|>GEO<|>Country that negotiated a swap of money in exchange for hostages)\n##\n##\n(\"entity\"<|>TIRUZIA<|>GEO<|>Capital of Firuzabad where the Aurelians were being held)\n##\n(\"entity\"<|>KROHAARA<|>GEO<|>Capital city in Quintara)\n##\n(\"entity\"<|>CASHION<|>GEO<|>Capital city in Aurelia)\n##\n(\"entity\"<|>SAMUEL NAMARA<|>PERSON<|>Aurelian who spent time in Tiruzia's Alhamia Prison)\n##\n(\"entity\"<|>ALHAMIA PRISON<|>GEO<|>Prison in Tiruzia)\n##\n(\"entity\"<|>DURKE BATAGLANI<|>PERSON<|>Aurelian journalist who was held hostage)\n##\n(\"entity\"<|>MEGGIE TAZBAH<|>PERSON<|>Bratinas national and environmentalist who was held hostage)\n##\n(\"relationship\"<|>FIRUZABAD<|>AURELIA<|>Firuzabad negotiated a hostage exchange with Aurelia<|>2)\n##\n(\"relationship\"<|>QUINTARA<|>AURELIA<|>Quintara brokered the hostage exchange between Firuzabad and Aurelia<|>2)\n##\n(\"relationship\"<|>QUINTARA<|>FIRUZABAD<|>Quintara brokered the hostage exchange between Firuzabad and Aurelia<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>ALHAMIA PRISON<|>Samuel Namara was a prisoner at Alhamia prison<|>8)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>MEGGIE TAZBAH<|>Samuel Namara and Meggie Tazbah were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>DURKE BATAGLANI<|>Samuel Namara and Durke Bataglani were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>MEGGIE TAZBAH<|>DURKE BATAGLANI<|>Meggie Tazbah and Durke Bataglani were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>FIRUZABAD<|>Samuel Namara was a hostage in Firuzabad<|>2)\n##\n(\"relationship\"<|>MEGGIE TAZBAH<|>FIRUZABAD<|>Meggie Tazbah was a hostage in Firuzabad<|>2)\n##\n(\"relationship\"<|>DURKE BATAGLANI<|>FIRUZABAD<|>Durke Bataglani was a hostage in Firuzabad<|>2)\n<|COMPLETE|>\n\n######################\n-Real Data-\n######################\nEntity_types: organization,person,geo,event\nText: en 1998, Potter observó que el beneficio de la\nsuplementación oral o enteral sobre mortalidad en adultos se mantenía únicamente\nen pacientes enfermos, desnutridos, sin patología neoplásica, de más de 70 años\nde edad, cuando se empleaban más de 400 kcal diarias, al menos durante 35 días.\nPosteriormente, Stratton analizó ensayos aleatorizados y no aleatorizados en dife-\nrentes grupos poblacionales, y concluyó que la suplementación en ancianos tenía\nefectos positivos sobre evolución nutricional y mortalidad.\nEn los últimos años se han publicado varios metaanálisis sobre suplementación en\neste grupo de edad. En uno de ellos (Milne, 2006), el análisis por subgrupos se\nrealizó atendiendo a la ubicación del enfermo (hospitalizado, institucionalizado o\nresidente en la comunidad; n = 9.187; 74% hospitalizados –ictus, fractura de ca-\ndera, enfermedad pulmonar obstructiva crónica, cirugía, insuficiencia cardiaca–).\nMientras que la evidencia en pacientes sin enfermedad aguda fue escasa en rela-\nción a morbimortalidad y función, en los enfermos hospitalizados ancianos se ob-\nservó menor mortalidad asociada al empleo de SO (175-1.000 kcal/día; 10-63 g de\nproteínas/día; suplementos comerciales, suplementos de base láctea y comidas enri-\nquecidas) en el grupo de desnutridos y en aquellos que presentaban más problemas\ngeriátricos. También disminuyeron las complicaciones y se describió un aumento en\nparámetros antropométricos como el peso corporal y la circunferencia muscular del\nbrazo. No se hallaron diferencias en estancia media, y no se midieron parámetros de       73\ncapacidad funcional y calidad de vida. De nuevo, para todas las ubicaciones, la mor-\ntalidad fue menor en sujetos suplementados de 75 o más años de edad, enfermos,\nque recibieron al menos 400 kcal diarias como suplemento durante 35 o más días.\nEn una revisión sistemática y metaanálisis (Cawood, 2012) se estudió la eficacia de los\nsuplementos orales hiperproteicos frente a controles (sin suplementación oral o con\nSO estándar) –seguimiento medio de 10 días a 2 años; 3.790 sujetos estudiados–.\nComparados con la ausencia de suplementación oral, los SO hiperproteicos fueron\neficaces en la reducción de complicaciones (–22%), de la estancia media (–3,8 días) y\nde los reingresos (–41%), sin diferencias en mortalidad. Además, se asociaron a me-\njoría en la fuerza prensora de la mano, y en la mayor parte de los estudios aumentó\nla calidad de vida. Los efectos nutricionales se concretaron en incrementos del peso\ncorporal, y de la ingesta de calorías y proteínas. No se encontraron diferencias en ac-\n---\nEnvejecimiento y NutriciónPAUTAS DE INTERVENCIÓN NUTRICIONAL EN ANCIANO FRÁGIL\n\n\n\n             tividades de la vida diaria, ni en movilidad, y los efectos sobre el apetito y el consumo\n             de otros alimentos no fueron claros. Solo en tres estudios se abordó el efecto de SO\n             hiperproteicos frente a SO estándar. No se observaron diferencias estadísticamente\n             significativas en la mayor parte de los eventos, y solo en uno de ellos se describió un\n             aumento del peso corporal, del índice de masa corporal (IMC) y de la masa grasa.\n             Desde un punto de vista económico y de coste-efectividad, merece la pena destacar\n             dos trabajos:\n                      En una revisión sistemática y metaanálisis reciente (Stratton, 2013), el empleo\n                      de suplementos orales tras el alta hospitalaria (entre 6 semanas y 1 año en\n                      régimen ambulatorio) se asoció de forma significativa a una reducción en\n                      el número de reingresos. La intervención aportó en los diferentes estudios\n                      entre 475 y 1.200 kcal/día y 21-60 g de proteínas/día. La mayor parte de los\n                      trabajos incluidos estuvieron centrados en sujetos con varias comorbilidades,\n                      de más de 65 años (la edad media de toda la muestra se situó en 80 años).\n                      Sobre una base de datos administrativa que contenía ingresos hospitalarios\n                      de 11 años (más de 40 millones de episodios), se estudió el impacto de los\n                      SO sobre estancia media, coste del proceso y riesgo de reingreso. Solo en\n                      un 1,6% de los ingresos se recogía la prescripción de SO. Utilizando una\n                      metodología novedosa, empare\n######################\nOutput:", "parameters": {"model": "gpt-4o-mini", "temperature": 0.0, "frequency_penalty": 0.0, "presence_penalty": 0.0, "top_p": 1.0, "max_tokens": 4000, "n": 1}, "history": null}